Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valdecoxib vs diclofenac for osteoarthritis of the knee
2004-001713-34Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valdecoxib in knee osteoarthritis (OA) (2 arms), sponsored by Pfizer. Primary endpoint: Patient's assessment of arthritis pain on VAS at Week 6. Started Feb 2005; status: terminated.
02
Drugs
valdecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2004-001713-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001713-34.